Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment
- 1 September 2001
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 106 (3) , 589-601
- https://doi.org/10.1016/s0306-4522(01)00295-0
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated micePublished by Elsevier ,2002
- Spontaneous Regeneration of Nigrostriatal Dopaminergic Neurons in MPTP-Treated C57BL/6 MiceBiochemical and Biophysical Research Communications, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neuronsBrain Research, 1995
- Different rates of age-related loss for four murine monoaminergic neuronal populationsNeurobiology of Aging, 1991
- Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatumBrain Research, 1989
- Urinary excretion of MPTP and its primary metabolites in miceLife Sciences, 1988
- The Clinical Syndrome of Striatal Dopamine DeficiencyNew England Journal of Medicine, 1985
- IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effectsLife Sciences, 1985